selected publications
- Aberrant splicing in Huntington's disease accompanies disrupted TDP-43 activity and altered m6A RNA modification. Nature neuroscience. 2025 Academic Article GET IT
-
MAPK13 stabilization via m6A mRNA modification limits anticancer efficacy of rapamycin.
The Journal of biological chemistry.
2023
Academic Article
GET IT
Times cited: 1 -
m6A in the Signal Transduction Network.
Molecules and cells.
2022
Review
GET IT
Times cited: 23